327 related articles for article (PubMed ID: 25698383)
21. Folliculotropism Does Not Affect Overall Survival in Mycosis Fungoides: Results from a Single-Center Cohort and Meta-Analysis.
Giberson M; Mourad A; Gniadecki R
Dermatology; 2017; 233(4):320-325. PubMed ID: 29169156
[TBL] [Abstract][Full Text] [Related]
22. Solitary mycosis fungoides: a distinct clinicopathologic entity with a good prognosis: a series of 15 cases and literature review.
Ally MS; Pawade J; Tanaka M; Morris S; Mitchell T; Child F; Wain M; Whittaker S; Robson A
J Am Acad Dermatol; 2012 Oct; 67(4):736-44. PubMed ID: 22533993
[TBL] [Abstract][Full Text] [Related]
23. Folliculotropic Mycosis Fungoides with Skewed T-cell Receptor CDR3 Motif: Suggestive of Lipid-antigen Selection?
Mantaka P; Malecka A; Trøen G; Helsing P; Gjersvik P; Beiske K; Delabie J
Acta Derm Venereol; 2017 Oct; 97(9):1081-1086. PubMed ID: 28597017
[TBL] [Abstract][Full Text] [Related]
24. Influence of the phenotype on mycosis fungoides prognosis, a retrospective cohort study of 160 patients.
Jaque A; Mereniuk A; Walsh S; Shear NH; Sade S; Zagorski B; Alhusayen R
Int J Dermatol; 2019 Aug; 58(8):933-939. PubMed ID: 30761533
[TBL] [Abstract][Full Text] [Related]
25. The different faces of mycosis fungoides: results of a single-center study.
Sidiropoulou P; Nikolaou V; Marinos L; Voudouri D; Komini E; Economidi A; Rigopoulos D; Stratigos A
Int J Dermatol; 2020 Mar; 59(3):314-320. PubMed ID: 31782525
[TBL] [Abstract][Full Text] [Related]
26. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
[TBL] [Abstract][Full Text] [Related]
27. Folliculotropic mycosis fungoides.
Hunzeker CM; Fangman W; Latkowski JA
Dermatol Online J; 2007 Jan; 13(1):5. PubMed ID: 17511938
[TBL] [Abstract][Full Text] [Related]
28. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
29. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.
Agar NS; Wedgeworth E; Crichton S; Mitchell TJ; Cox M; Ferreira S; Robson A; Calonje E; Stefanato CM; Wain EM; Wilkins B; Fields PA; Dean A; Webb K; Scarisbrick J; Morris S; Whittaker SJ
J Clin Oncol; 2010 Nov; 28(31):4730-9. PubMed ID: 20855822
[TBL] [Abstract][Full Text] [Related]
30. New insights into folliculotropic mycosis fungoides (FMF): A single-center experience.
Hodak E; Amitay-Laish I; Atzmony L; Prag-Naveh H; Yanichkin N; Barzilai A; Kershenovich R; Feinmesser M
J Am Acad Dermatol; 2016 Aug; 75(2):347-55. PubMed ID: 27245278
[TBL] [Abstract][Full Text] [Related]
31. Prognostic miRNA classifier in early-stage mycosis fungoides: development and validation in a Danish nationwide study.
Lindahl LM; Besenbacher S; Rittig AH; Celis P; Willerslev-Olsen A; Gjerdrum LMR; Krejsgaard T; Johansen C; Litman T; Woetmann A; Odum N; Iversen L
Blood; 2018 Feb; 131(7):759-770. PubMed ID: 29208599
[TBL] [Abstract][Full Text] [Related]
32. Retrospective Analysis of Prognostic Factors in 187 Cases of Transformed Mycosis Fungoides.
Talpur R; Sui D; Gangar P; Dabaja BS; Duvic M
Clin Lymphoma Myeloma Leuk; 2016 Jan; 16(1):49-56. PubMed ID: 26702474
[TBL] [Abstract][Full Text] [Related]
33. Syringotropic Mycosis Fungoides: A Variant of Folliculotropic or a Distinct Subtype of Adnexotropic Mycosis Fungoides?
Nussbaum D; Eleryan M; Samaan C; Glass F; Prussick R
J Drugs Dermatol; 2022 Dec; 21(12):1362-1364. PubMed ID: 36468959
[TBL] [Abstract][Full Text] [Related]
34. Recognizing large-cell transformation of mycosis fungoides.
Herrmann JL; Hughey LC
J Am Acad Dermatol; 2012 Oct; 67(4):665-72. PubMed ID: 22261416
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E
Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151
[TBL] [Abstract][Full Text] [Related]
36. Transformed mycosis fungoides: clinicopathological features and outcome.
Barberio E; Thomas L; Skowron F; Balme B; Dalle S
Br J Dermatol; 2007 Aug; 157(2):284-9. PubMed ID: 17573879
[TBL] [Abstract][Full Text] [Related]
37. Early-stage mycosis fungoides variants: case-based review.
Cho-Vega JH; Tschen JA; Duvic M; Vega F
Ann Diagn Pathol; 2010 Oct; 14(5):369-85. PubMed ID: 20850703
[TBL] [Abstract][Full Text] [Related]
38. Folliculotropic mycosis fungoides: clinical and epidemiological evaluation in a single center in Brazil.
Deonizio JM; Ascef RD; Sanches JA
Int J Dermatol; 2016 May; 55(5):e256-61. PubMed ID: 26711732
[TBL] [Abstract][Full Text] [Related]
39. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
40. miRNA expression profiling of mycosis fungoides.
van Kester MS; Ballabio E; Benner MF; Chen XH; Saunders NJ; van der Fits L; van Doorn R; Vermeer MH; Willemze R; Tensen CP; Lawrie CH
Mol Oncol; 2011 Jun; 5(3):273-80. PubMed ID: 21406335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
